United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45865-244_12645512-7cb8-0532-e063-6294a90acbe5
- Product NDC
- 45865-244
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Medsource Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080926
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, FILM COATED in 1 BOTTLE (45865-244-14) · 45865-244-14
- 20 TABLET, FILM COATED in 1 BOTTLE (45865-244-20) · 45865-244-20
- 30 TABLET, FILM COATED in 1 BOTTLE (45865-244-30) · 45865-244-30
- 60 TABLET, FILM COATED in 1 BOTTLE (45865-244-60) · 45865-244-60
- 90 TABLET, FILM COATED in 1 BOTTLE (45865-244-90) · 45865-244-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →